Anxiety is a common and significant symptom of menopause and perimenopause, largely due to hormone fluctuations. Numerous studies have focused on the potential benefits of hormone therapy in reducing anxiety. A new systematic review indicates the treatment does not consistently impact anxiety symptoms in midlife women. Results of the review were presented at the 2025 Annual Meeting of The Menopause Society in Orlando, held October 21–25.
This article was originally published on MedicalXpress.com
